Innate Pharma Files Its 2019 Universal Registration Document (Document d’enregistrement universel) and Its 2019 Annual Report on Form 20-F

    NEXT STORY
    Global Antiparasitic Drugs market to surpass US$ 10,842.7 million by 2027, Says CMI
    PREV STORY
    Y-mAbs Announces Appointment of Laura J. Hamill to its Board of Directors
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Shire plc: Director/PDMR Shareholding

    Director/PDMR Shareholding July 2, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) Notification of ...

    author_avatar
    NASDAQ Market News

    Verona Pharma Reports Positive Interim Data with Ensifentrine Dry Powder Inhaler Formulation in First of Two-Part Phase 2 Clinical Trial in COPD

    author_avatar
    NASDAQ Market News

    Tetraphase Pharmaceuticals Initiates Phase 1 Clinical Trial for TP-271

    WATERTOWN, Mass., Jan. 19, 2016 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today announced ...

    author_avatar
    NASDAQ Market News